APA (7th ed.) Citation

Woo, T., Han, J., Kim, Y., Hwang, Y. j., Lee, M., Kang, S., . . . Park, B. (2025). Inhibition of SOD1 trimerization is a novel drug target for ALS disease. Translational Neurodegeneration, 14(1), 1. https://doi.org/10.1186/s40035-025-00483-8

Chicago Style (17th ed.) Citation

Woo, Tae-Gyun, et al. "Inhibition of SOD1 Trimerization Is a Novel Drug Target for ALS Disease." Translational Neurodegeneration 14, no. 1 (2025): 1. https://doi.org/10.1186/s40035-025-00483-8.

MLA (9th ed.) Citation

Woo, Tae-Gyun, et al. "Inhibition of SOD1 Trimerization Is a Novel Drug Target for ALS Disease." Translational Neurodegeneration, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s40035-025-00483-8.